| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
|
J Clin Oncol
|
2012
|
5.59
|
|
2
|
The prognostic significance of patient-reported outcomes in cancer clinical trials.
|
J Clin Oncol
|
2008
|
3.14
|
|
3
|
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
|
Lancet Oncol
|
2009
|
2.64
|
|
4
|
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
|
J Natl Cancer Inst
|
2011
|
2.56
|
|
5
|
Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
|
Lancet Oncol
|
2005
|
2.26
|
|
6
|
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
|
J Clin Oncol
|
2005
|
2.15
|
|
7
|
The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care.
|
Eur J Cancer
|
2005
|
1.97
|
|
8
|
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.
|
Eur J Cancer
|
2008
|
1.95
|
|
9
|
What is the effect of systemic anticancer treatment on cognitive function?
|
Lancet Oncol
|
2004
|
1.89
|
|
10
|
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
|
Eur J Cancer
|
2010
|
1.84
|
|
11
|
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
|
J Clin Oncol
|
2007
|
1.72
|
|
12
|
Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?
|
J Clin Oncol
|
2003
|
1.68
|
|
13
|
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.
|
J Clin Oncol
|
2013
|
1.62
|
|
14
|
Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach.
|
Eur J Cancer
|
2007
|
1.62
|
|
15
|
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.
|
J Clin Oncol
|
2008
|
1.57
|
|
16
|
Do quality-of-life randomized clinical trials support clinicians in their decision-making?
|
J Clin Oncol
|
2002
|
1.45
|
|
17
|
Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.
|
Stat Med
|
2002
|
1.28
|
|
18
|
Review on quality of life issues in patients with primary brain tumors.
|
Oncologist
|
2010
|
1.24
|
|
19
|
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?
|
Eur J Cancer
|
2005
|
1.20
|
|
20
|
Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study.
|
J Clin Oncol
|
2004
|
1.17
|
|
21
|
Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.
|
J Clin Oncol
|
2008
|
1.16
|
|
22
|
Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.15
|
|
23
|
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
|
Support Care Cancer
|
2010
|
1.15
|
|
24
|
International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
|
Cancer
|
2011
|
1.14
|
|
25
|
Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials.
|
Cancer
|
2003
|
1.14
|
|
26
|
A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales.
|
J Clin Epidemiol
|
2008
|
1.12
|
|
27
|
Assessing HRQOL: a neglected issue for high-grade glioma.
|
Lancet Oncol
|
2003
|
1.11
|
|
28
|
Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression.
|
Health Qual Life Outcomes
|
2010
|
1.11
|
|
29
|
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
|
Cancer
|
2013
|
1.10
|
|
30
|
Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group.
|
J Clin Oncol
|
2004
|
1.09
|
|
31
|
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
|
Eur J Cancer
|
2007
|
1.07
|
|
32
|
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
|
Eur J Cancer
|
2008
|
1.07
|
|
33
|
Fatigue and quality of life: lessons from the real world.
|
Oncologist
|
2003
|
1.02
|
|
34
|
Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).
|
Psychooncology
|
2012
|
1.01
|
|
35
|
Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.
|
J Clin Oncol
|
2011
|
1.00
|
|
36
|
The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database.
|
J Clin Epidemiol
|
2008
|
0.98
|
|
37
|
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study.
|
J Clin Oncol
|
2007
|
0.97
|
|
38
|
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98.
|
Psychooncology
|
2013
|
0.97
|
|
39
|
Treatment satisfaction as an outcome measure in cancer clinical treatment trials.
|
Expert Rev Pharmacoecon Outcomes Res
|
2002
|
0.94
|
|
40
|
Predictive factors for overall quality of life in patients with advanced cancer.
|
Support Care Cancer
|
2013
|
0.94
|
|
41
|
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20).
|
J Clin Oncol
|
2003
|
0.94
|
|
42
|
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors.
|
J Neurooncol
|
2013
|
0.93
|
|
43
|
Radiotherapy in conjunction with intravenous infusion of 180 mg of disodium pamidronate in management of osteolytic metastases from breast cancer: clinical evaluation, biochemical markers, quality of life, and monitoring of recalcification using assessments of gray-level histogram in plain radiographs.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.91
|
|
44
|
Evaluating health-related quality of life and symptom burden in brain tumour patients: instruments for use in experimental trials and clinical practice.
|
Curr Opin Neurol
|
2008
|
0.91
|
|
45
|
Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data.
|
Qual Life Res
|
2009
|
0.90
|
|
46
|
When a parent has cancer: challenges to patients, their families and health providers.
|
Expert Rev Pharmacoecon Outcomes Res
|
2012
|
0.88
|
|
47
|
Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
|
Expert Rev Pharmacoecon Outcomes Res
|
2009
|
0.88
|
|
48
|
Toward a clearer understanding of the prognostic value of health-related quality-of-life parameters in breast cancer.
|
J Clin Oncol
|
2005
|
0.87
|
|
49
|
Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases.
|
Eur J Cancer
|
2009
|
0.86
|
|
50
|
Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment.
|
Support Care Cancer
|
2013
|
0.85
|
|
51
|
Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases.
|
Qual Life Res
|
2013
|
0.85
|
|
52
|
Standards are needed for quality of life clinical trials.
|
BMJ
|
2002
|
0.83
|
|
53
|
The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22.
|
Expert Rev Pharmacoecon Outcomes Res
|
2013
|
0.82
|
|
54
|
An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
|
Support Care Cancer
|
2012
|
0.82
|
|
55
|
Comparison of three shortened questionnaires for assessment of quality of life in advanced cancer.
|
J Palliat Med
|
2014
|
0.82
|
|
56
|
Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer.
|
Expert Rev Pharmacoecon Outcomes Res
|
2013
|
0.82
|
|
57
|
Health-related quality of life in patients with brain tumors: limitations and additional outcome measures.
|
Curr Neurol Neurosci Rep
|
2013
|
0.81
|
|
58
|
Trends in translation requests and arising issues regarding cultural adaptation.
|
Expert Rev Pharmacoecon Outcomes Res
|
2011
|
0.81
|
|
59
|
Health-related quality of life and symptom research in glioblastoma multiforme patients.
|
Expert Rev Pharmacoecon Outcomes Res
|
2005
|
0.81
|
|
60
|
Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26.
|
Qual Life Res
|
2012
|
0.80
|
|
61
|
Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients.
|
J Comp Eff Res
|
2014
|
0.80
|
|
62
|
Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17.
|
Support Care Cancer
|
2014
|
0.79
|
|
63
|
The practical impact of differential item functioning analyses in a health-related quality of life instrument.
|
Qual Life Res
|
2009
|
0.79
|
|
64
|
Comparison of the EORTC QLQ-BN20 and the FACT-Br quality of life questionnaires for patients with primary brain cancers: a literature review.
|
Support Care Cancer
|
2014
|
0.78
|
|
65
|
EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review.
|
J Comp Eff Res
|
2015
|
0.78
|
|
66
|
Joint modeling of longitudinal health-related quality of life data and survival.
|
Qual Life Res
|
2014
|
0.78
|
|
67
|
Factors influencing health related quality of life in cancer patients with bone metastases.
|
J Palliat Med
|
2013
|
0.77
|
|
68
|
EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer?
|
Palliat Med
|
2006
|
0.77
|
|
69
|
Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiative.
|
Eur J Cancer Care (Engl)
|
2009
|
0.77
|
|
70
|
An integrated psychological strategy for advanced colorectal cancer patients.
|
Health Qual Life Outcomes
|
2006
|
0.77
|
|
71
|
Interpretation of differential item functioning analyses using external review.
|
Expert Rev Pharmacoecon Outcomes Res
|
2010
|
0.77
|
|
72
|
The process of reconciliation: evaluation of guidelines for translating quality-of-life questionnaires.
|
Expert Rev Pharmacoecon Outcomes Res
|
2012
|
0.76
|
|
73
|
Quality of life in breast cancer patients: measurement issues in cancer clinical trials.
|
Expert Rev Pharmacoecon Outcomes Res
|
2002
|
0.76
|
|
74
|
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
|
Expert Rev Pharmacoecon Outcomes Res
|
2011
|
0.76
|
|
75
|
Confusion about European Organisation for Research and Treatment of Cancer Quality of Life Prostate module (EORTC QLQ-PR25): a response.
|
Expert Rev Pharmacoecon Outcomes Res
|
2002
|
0.75
|
|
76
|
Palliative-care trials: how best to publish findings?
|
Lancet Oncol
|
2008
|
0.75
|
|
77
|
Variability and sample size requirements for health-related quality-of-life measures: understanding the challenges facing investigators.
|
J Clin Oncol
|
2005
|
0.75
|
|
78
|
Guidelines for the use of epoetin: have quality-of-life benefits been proven?
|
J Clin Oncol
|
2003
|
0.75
|
|
79
|
Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module.
|
Melanoma Res
|
2015
|
0.75
|
|
80
|
Fatigue assessment in cancer clinical trials.
|
Expert Rev Pharmacoecon Outcomes Res
|
2002
|
0.75
|
|
81
|
An evaluation of the response category translations of the EORTC QLQ-C30 questionnaire.
|
Qual Life Res
|
2012
|
0.75
|
|
82
|
Short- and long-term HRQOL issues following brachytherapy for prostate cancer.
|
Expert Rev Pharmacoecon Outcomes Res
|
2004
|
0.75
|
|
83
|
Health-related quality of life and cancer.
|
Expert Rev Pharmacoecon Outcomes Res
|
2009
|
0.75
|
|
84
|
External beam radiotherapy in prostate cancer patients: short- and long-term health-related quality of life issues.
|
Expert Rev Pharmacoecon Outcomes Res
|
2003
|
0.75
|
|
85
|
Promoting pan-European cancer research for the benefit of all cancer patients.
|
Expert Rev Pharmacoecon Outcomes Res
|
2012
|
0.75
|